UBS in talks on Indian minority-owned wealth joint venture, say sources
UBS is in talks to form an Indian wealth management joint venture with Mumbai-based 360 One WAM, two sources with direct ...
Financial Planning5h
Majority of wealthy investors plan portfolio changes ahead of election, UBS finds
A recent UBS Investor Watch report highlights a deeply divided country in which many view the economy as the main issue this ...
UBS initiates 'sell' calls on slew of pharma majors; sees growth slowdown in India & US mkts
UBS initiated 'sell' calls on Dr Reddy's Laboratories Lupin, Aurobindo Pharma and Zydus Lifesciences while picking Sun Pharma ...
Italy picks UBS Europe, White & Case as advisers for Poste stake sale
Italy's Treasury said on Friday it had picked UBS Europe SE and White & Case Europe LLP as financial and legal advisers for ...
Mexico’s Peso to Gain as Political Uncertainty Ebbs, UBS Says
Mexico’s peso is set to strengthen through the first half of next year as investors grow more comfortable with the new ...
Euromoney1h
The world’s best bank for FX trading technology: UBS
UBS has increased its investment and development of leading FX technology builds notably over the past three years, ...
UBS Loses $2.8 Billion Advisor Team to RBC Wealth Management
The latest addition to RBC’s growing wealth operation is a 15-person team that is joining the firm’s Atlanta office.
Brokerage Radar: UBS favours Sun Pharma, Cipla; Morgan Stanley sees relief for IT sector
Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes real estate, ...
UBS Sticks to Their Buy Rating for Visa (V)
UBS analyst Timothy Chiodo maintained a Buy rating on Visa (V – Research Report) today and set a price target of $320.00. The ...
Euromoney1h
The world’s best FX bank: UBS
Through the breadth of its market liquidity, product scale and global footprint, UBS has built a strong reputation as the ...
Certara gains as UBS upgrades citing compelling buy
Certara (CERT) stock rises 10% after UBS upgrade to Buy citing strong growth potential in biosimulation software and Model ...